Overview

Insulin Signaling in Skeletal Muscle

Status:
Withdrawn

Trial end date:
2025-06-01

Target enrollment:

Participant gender:

Summary

The insulin sensitizing effects of metformin and pioglitazone in the skeletal muscle remain unknown. Our group aims to analyze molecular changes within the skeletal muscle of pre-diabetic patients through the use of a clinical trial in humans.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Wayne State University

Treatments:

Metformin
Pioglitazone